Michael Baker, Chief Executive Officer & Managing Director at Arovella Therapeutics Limited, holds 6.57M shares in Arovella Therapeutics Limited (Ticker: AU:ALA). Most recently, Michael Baker Bought AU$220,000 shares of Arovella Therapeutics Limited on Mar 27, 2024 for an estimated value of 31.28K.